<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="publisher-id">cshperspectmed</journal-id>
<journal-id journal-id-type="hwp">cshperspectmed</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Perspectives in Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2157-1422</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
<publisher-loc>Cold Spring Harbor, New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28250017</article-id>
<article-id pub-id-type="pmc">5334248</article-id>
<article-id pub-id-type="doi">10.1101/cshperspect.a026864</article-id>
<article-id pub-id-type="publisher-id">a026864</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>106</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Perspectives</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Use of Next-Generation Sequencing for Research and Diagnostics for Intellectual Disability</article-title>
<alt-title alt-title-type="left-running">R. Harripaul et al.</alt-title>
<alt-title alt-title-type="right-running">Next-Generation Sequencing and Intellectual Disability</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Harripaul</surname>
<given-names>Ricardo</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noor</surname>
<given-names>Abdul</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ayub</surname>
<given-names>Muhammad</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vincent</surname>
<given-names>John B.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Molecular Neuropsychiatry &amp; Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario M5T 1R8, Canada</aff>
<aff id="af2"><label>2</label>Institute of Medical Science, University of Toronto, Toronto, Ontario M5T 1R8, Canada</aff>
<aff id="af3"><label>3</label>Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1Z5, Canada</aff>
<aff id="af4"><label>4</label>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1Z5, Canada</aff>
<aff id="af5"><label>5</label>Department of Psychiatry, Queen’s University, Kingston, Ontario K7L 7X3, Canada</aff>
<aff id="af6"><label>6</label>Department of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8, Canada</aff>
<author-notes>
<corresp>
<italic>Correspondence:</italic>
<email>john.vincent@camh.net</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<volume>7</volume>
<issue>3</issue>
<elocation-id>a026864</elocation-id>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.perspectivesinmedicine.org/site/misc/terms.xhtml">Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved</ext-link>
</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="cshperspectmed-NGS-a026864.pdf"></self-uri>
<abstract>
<p>Genetic or genomic mutation is a major cause of intellectual disability (ID). However, despite the generally anticipated strong genotype/phenotype correlation for ID, there are huge obstacles to gene identification, except perhaps where very distinct syndromic features are observed, because of the high degree of genetic heterogeneity and wide variability of phenotype for different mutations or even with the same mutation within a single gene. A recent review estimates in excess of 2500 genes for ID. Fortunately for researchers and diagnosticians alike, the recent advent of massively parallel sequencing technologies, or next-generation sequencing (NGS) has made an apparently impossible task tractable. Here, we review the ongoing research endeavors to identify new disease genes, as well as strategies and approaches at the clinical level.</p>
</abstract>
<abstract abstract-type="precis">
<p>The majority of genes that cause intellectual disabilities (perhaps &gt;2500) have remained unidentified. But advances in next-generation sequencing are simplifying this task and may lead to improved diagnostics and clinical care.</p>
</abstract>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>